Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | Director · CEO | August 16, 2024 | August 20, 2024 |
| AEON Biopharma, Inc.AEON · Entity 7859 | CHIEF FINANCIAL OFFICER | April 02, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date August 16, 2024 · Filed August 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,636 |
Reported balance
After 2024-08-16 transaction · row 1
1 source rowRow 1 · 2024-08-16 · Grant · Acquired 5,000 · Balance 100,636 F1: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan.
AEON Biopharma, Inc.
Report date April 02, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 754,717 |
Reported balance
After 2026-04-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-02 · Grant · Acquired 754,717 · Balance 754,717 F1: Represents an award of restricted stock units granted on April 1, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units granted on April 1, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2018 Filed Aug 15, 2018 20:52 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 458 | $2.78 | $1,273.24 |
DisclosureSEC source: 0001209191-18-046834 · doc4.xml · nonDerivative · entry 2 Bencich John · CIK 0001477056 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120 F3 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.77 to $2.815 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:52 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046834 · doc4.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. F2 · balance_after: On May 23, 2018, the Issuer effected a 1-for-10 split of its common stock (the "Stock Split") resulting in a decrease in the reporting person's ownership of 1,223 shares of common stock. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001209191-18-044352 · doc4.xml · derivative · entry 1 Bencich John · CIK 0001477056 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-07-26 F1 · derivative.exercise_date: The options vest in monthly installments over 48 months commencing one month from July 26 2018. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 18:30 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052372 · doc4.xml · derivative · entry 3 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455 Underlying: Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of August 12, 2014 and (ii) the first day thereafter during which the issuer's trading window is open. F5 · derivative.expiration_date: The RSUs expire 30 days from the date they vest. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 18:30 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 149 | $3.09 | $460.41 |
DisclosureSEC source: 0001209191-17-052372 · doc4.xml · nonDerivative · entry 2 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of RSUs and does not represent a sale by the reporting person. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 18:30 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052372 · doc4.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:06 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 274,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001209191-17-047603 · doc4.xml · derivative · entry 3 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 274,000 shares Expires 2027-08-01 F4 · derivative.exercise_date: The options vest as to 25% on August 1, 2018 and thereafter in monthly installments over 36 months. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:06 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantRestricted Stock Unit (RSU) · Derivative | 54,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047603 · doc4.xml · derivative · entry 2 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,800 Underlying: Common Stock · 54,800 shares Expires 2021-08-01 F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 01, 2017 Filed Sep 12, 2017 18:43 UTC Amendment | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 274,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-17-052375 · doc4a.xml · derivative · entry 1 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 274,000 shares Expires 2027-08-01 F1 · derivative.exercise_price: This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant. All other terms remain the same. F2 · derivative.exercise_date: The options vest as to 25% on August 1, 2018 and thereafter in monthly installments over 36 months. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:42 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003462 · doc4.xml · derivative · entry 3 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 3,125 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:42 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Tax withholdingCommon Stock | 1,021 | $0.63 | $643.23 |
DisclosureSEC source: 0001209191-17-003462 · doc4.xml · nonDerivative · entry 2 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,588 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:42 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003462 · doc4.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.